Pura Vida Investments’s Nautilus Biotechnolgy NAUT Stock Holding History

Pura Vida Investments’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-244,698	Closed	-$1.06M	–	252
2022 Q1	$1.06M	Buy	244,698 +100,900	+70%	+$414K	0.03%	183
2021 Q4	$745K	Sell	143,798 -4,502	-3%	-$24.1K	0.03%	194
2021 Q3	$911K	Sell	148,300 -58,779	-28%	-$468K	0.03%	227
2021 Q2	$2.09M	Sell	207,079 -88,475	-30%	-$958K	0.07%	157
2021 Q1	$4.07M	Buy	+295,554	New	+$4.1M	0.12%	129

Other funds holding NAUT

AEPBI

AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

MVG

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

ACI

Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

Pura Vida Investments's NAUT Position: Q2 2022 in Review

Pura Vida Investments sold out of Nautilus Biotechnolgy (NAUT) in Q2 2022, closing a stake of 244,698 shares — an estimated $1.06M sold.

Pura Vida Investments first reported a position in NAUT in Q1 2021 and held it in 5 quarters. The position peaked at $4.07M in Q1 2021. 83 funds tracked by Wall St. Rank hold NAUT as of Q2 2022.

Pura Vida Investments reported no remaining Nautilus Biotechnolgy position as of Q2 2022 after selling out during the quarter.
Pura Vida Investments sold 244,698 Nautilus Biotechnolgy shares in Q2 2022, an estimated $1.06M.
Pura Vida Investments first reported a position in Nautilus Biotechnolgy in Q1 2021 and held it in 5 quarters.
Pura Vida Investments's Nautilus Biotechnolgy position peaked at $4.07M in Q1 2021.
83 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2022.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.